Therefore, it remains unclear which of these approaches works best for specific patient populations. Although some clinical guidelines recommend certain device features such as portability, 16 in general, guidelines do not make recommendations for or against specific IPCDs or device categories. Some devices also include an hour meter that may facilitate adherence monitoring. 32 By contrast, non-portable devices must be removed when the patient ambulates.
#PURPOSE OF PNEUMATIC COMPRESSION DEVICE PORTABLE#
Portable IPCDs offer the potential advantage of continued use during ambulation in the early post-operative period. 30, 31 In general, IPCDs can be categorized into either single-chamber or multi-chamber devices, constant pressure or sequential pressure devices, slow-gradual or rapid inflation devices, and portable or non-portable devices. There are a wide variety of IPCDs currently available that differ in anatomical location of the sleeve garment, number and location of air bladders, patterns of compression cycles, and duration of inflation time and deflation time.
27 - 29 These effects can be achieved by mechanical compression of the foot or calf alone, or by sequential compression of either the foot and calf, or the calf and thigh. It is hypothesized that IPCDs prevent DVT formation through 2 mechanisms, namely, by decreasing venous stasis and activating fibrinolysis.
INTERMITTENT PNEUMATIC COMPRESSION DEVICES 17 - 19 Although IPCDs can offer protection against VTE, 20 - 22 compliance is often suboptimal, 23, 24 and efficacy may vary importantly across various devices.
#PURPOSE OF PNEUMATIC COMPRESSION DEVICE MANUAL#
11, 12 Mechanical prophylaxis with intermittent pneumatic compression devices (IPCDs) is recommended, particularly in populations at high risk of bleeding, 13 - 16 due to the decreased risk of major bleeding and surgical site bleeding associated with IPCDs. Pneumatic compression devices are sometimes used as part of the treatment of peripheral edema of venous-lymphatic origin as are techniques for manual drainage. Pharmacological options include anticoagulation ( eg, low molecular weight heparin, new oral anticoagulants, or warfarin) and aspirin, but these may increase the risk of bleeding. 9, 10Ĭlinical practice guidelines generally recommend either pharmacological or mechanical VTE prophylaxis. 6 - 8 VTE prophylaxis is recommended for approximately 60% of high-risk surgical patients and for the 40% of hospitalized medical patients at risk for VTE. Its designed to move more blood1 to help prevent stasis,1 track compliance2 and educate patients and clinicians about the risk of VTE. In high-risk groups, such as post-operative surgical patients and acutely ill medical patients, 1 - 5 VTE is a leading cause of morbidity and mortality. Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and pulmonary embolism (PE), is a serious potential complication in hospitalized patients.
0 kommentar(er)
